[{"id":"74bef0ec-e64e-4efc-a1bb-a54c18f7a818","acronym":"","url":"https://clinicaltrials.gov/study/NCT04220684","created_at":"2021-01-18T20:32:37.858Z","updated_at":"2025-02-25T16:32:03.029Z","phase":"Phase 1","brief_title":"Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML","source_id_and_acronym":"NCT04220684","lead_sponsor":"Sumithira Vasu","biomarkers":" IL21","pipe":"","alterations":" ","tags":["IL21"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • azacitidine • decitabine • fludarabine IV • SAR445419"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 19","initiation":"Initiation: 06/11/2020","start_date":" 06/11/2020","primary_txt":" Primary completion: 10/22/2024","primary_completion_date":" 10/22/2024","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2025-02-07"},{"id":"a992df32-0f66-461e-bf5a-13d5da20f1e2","acronym":"","url":"https://clinicaltrials.gov/study/NCT04808115","created_at":"2022-04-24T09:03:02.155Z","updated_at":"2024-07-02T16:36:06.412Z","phase":"Phase 1","brief_title":"IIT PH1 KDS-1001 in Patients With CML","source_id_and_acronym":"NCT04808115","lead_sponsor":"Lindsay Rein, MD","biomarkers":" ABL1 • BCR","pipe":"","alterations":" ","tags":["ABL1 • BCR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SAR445419"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 05/01/2023","start_date":" 05/01/2023","primary_txt":" Primary completion: 09/01/2025","primary_completion_date":" 09/01/2025","study_txt":" Completion: 09/01/2027","study_completion_date":" 09/01/2027","last_update_posted":"2022-07-29"},{"id":"73bcc72d-b32e-451f-aeac-f9a33dd41196","acronym":"","url":"https://clinicaltrials.gov/study/NCT02809092","created_at":"2021-01-18T13:46:41.925Z","updated_at":"2024-07-02T16:36:54.606Z","phase":"Phase 1/2","brief_title":"Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia","source_id_and_acronym":"NCT02809092","lead_sponsor":"Hospital de Clinicas de Porto Alegre","biomarkers":" IL21","pipe":"","alterations":" ","tags":["IL21"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • SAR445419"],"overall_status":"Unknown status","enrollment":" Enrollment 30","initiation":"Initiation: 04/01/2017","start_date":" 04/01/2017","primary_txt":" Primary completion: 09/30/2019","primary_completion_date":" 09/30/2019","study_txt":" Completion: 09/01/2020","study_completion_date":" 09/01/2020","last_update_posted":"2019-10-15"}]